Financial Fitness Check: Examining U.S. Physical Therapy, Inc (USPH)’s Key Ratios

Kiel Thompson

For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.

In the latest session, U.S. Physical Therapy, Inc (NYSE: USPH) closed at $84.24 up 6.80% from its previous closing price of $78.88. In other words, the price has increased by $6.80 from its previous closing price. On the day, 0.63 million shares were traded. USPH stock price reached its highest trading level at $85.4 during the session, while it also had its lowest trading level at $76.7701.

Ratios:

For a deeper understanding of U.S. Physical Therapy, Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 41.18 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 22.00. For the most recent quarter (mrq), Quick Ratio is recorded 1.20 and its Current Ratio is at 1.20. In the meantime, Its Debt-to-Equity ratio is 0.61 whereas as Long-Term Debt/Eq ratio is at 0.51.

On December 16, 2024, BofA Securities Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $100 to $115.

On December 16, 2024, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $113.JMP Securities initiated its Mkt Outperform rating on December 16, 2024, with a $113 target price.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 24 ’25 when REEVE GRAHAM D. sold 743 shares for $71.01 per share. The transaction valued at 52,760 led to the insider holds 20,740 shares of the business.

Gilmartin Kathleen A bought 4,000 shares of USPH for $276,000 on Nov 20 ’25. The Director now owns 24,786 shares after completing the transaction at $69.00 per share. On Nov 21 ’25, another insider, Graham D. Reeve, who serves as the Affiliate of the company, bought 743 shares for $71.01 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, USPH now has a Market Capitalization of 1280795008 and an Enterprise Value of 1835960960. As of this moment, U.S.’s Price-to-Earnings (P/E) ratio for their current fiscal year is 35.44, and their Forward P/E ratio for the next fiscal year is 28.20. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.93. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.69 while its Price-to-Book (P/B) ratio in mrq is 2.54. Its current Enterprise Value per Revenue stands at 2.445 whereas that against EBITDA is 18.482.

Stock Price History:

The Beta on a monthly basis for USPH is 1.29, which has changed by -0.10799503 over the last 52 weeks, in comparison to a change of 0.16067612 over the same period for the S&P500. Over the past 52 weeks, USPH has reached a high of $93.50, while it has fallen to a 52-week low of $62.77. The 50-Day Moving Average of the stock is 7.20%, while the 200-Day Moving Average is calculated to be 7.73%.

Shares Statistics:

For the past three months, USPH has traded an average of 169.92K shares per day and 142230 over the past ten days. A total of 15.20M shares are outstanding, with a floating share count of 14.90M. Insiders hold about 2.03% of the company’s shares, while institutions hold 105.62% stake in the company. Shares short for USPH as of 1765756800 were 764911 with a Short Ratio of 4.50, compared to 1763078400 on 853073. Therefore, it implies a Short% of Shares Outstanding of 764911 and a Short% of Float of 6.0.

Dividends & Splits

According to the company, the forward annual dividend rate for USPH is 1.80, from 1.79 in the trailing year. Against a Trailing Annual Dividend Yield of 0.022692699. The stock’s 5-year Average Dividend Yield is 1.65. The current Payout Ratio is 95.62% for USPH, which recently paid a dividend on 2025-11-17 with an ex-dividend date of 2025-11-17. Stock splits for the company last occurred on 2001-06-29 when the company split stock in a 3:2 ratio.

Earnings Estimates

As of right now, 6.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is $0.56, with high estimates of $0.73 and low estimates of $0.47.

Analysts are recommending an EPS of between $2.69 and $2.56 for the fiscal current year, implying an average EPS of $2.64. EPS for the following year is $2.99, with 7.0 analysts recommending between $3.23 and $2.77.

Revenue Estimates

A total of 6 analysts believe the company’s revenue will be $200.1M this quarter.It ranges from a high estimate of $204.79M to a low estimate of $196.6M. As of. The current estimate, U.S. Physical Therapy, Inc’s year-ago sales were $180.45MFor the next quarter, 6 analysts are estimating revenue of $197.21M. There is a high estimate of $198.3M for the next quarter, whereas the lowest estimate is $195.22M.

A total of 7 analysts have provided revenue estimates for USPH’s current fiscal year. The highest revenue estimate was $783.06M, while the lowest revenue estimate was $774.86M, resulting in an average revenue estimate of $777.88M. In the same quarter a year ago, actual revenue was $671.35MBased on 7 analysts’ estimates, the company’s revenue will be $826.21M in the next fiscal year. The high estimate is $845.4M and the low estimate is $814.52M.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.